ABT-869 is a small molecule ATP-competitive inhibitor that potently targets VEGF and PDGF receptor tyrosine kinases. Its active hydrophilic metabolite, A-849529, facilitates research into angiogenesis and tumor growth in both cellular assays and animal models.
Molekulargewicht:
405.38
CAS Nummer:
[819058-88-3]
Formel:
C21H16FN5O3
Target-Kategorie:
Drug Metabolite
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
